Inventor · disambiguated record
Tadimeti Rao
Also filed as: RAO TADIMETI · RAO TADIMETI S
14 granted patents·14 pending applications·54 citations·filing 2007–2016
91Inventor score
Top patents by PatentIndex Score
28 records- 0189US8299084B2Piperidine inhibitors of Janus kinase 3RAO TADIMETI·Filed 2010·Granted Oct 30, 2012·11 cites·5 claims
- 0288US9498481B2Cyclopropyl modulators of P2Y12 receptorAUSPEX PHARMACEUTICALS INC·Filed 2015·Granted Nov 22, 2016·5 cites·16 claims
- 0388US8575348B2Quinolone inhibitors of lipoprotein-associated phospholipase A2RAO TADIMETI·Filed 2010·Granted Nov 5, 2013·13 cites·26 claims
- 0485US9255104B2Cyclopropyl modulators of P2Y12 receptorAUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Feb 9, 2016·5 cites·16 claims
- 0583US9585884B2Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2AUSPEX PHARMACEUTICALS INC·Filed 2013·Granted Mar 7, 2017·5 cites·33 claims
- 0683US8802850B2Cyclopropyl modulators of P2Y12 receptorRAO TADIMETI·Filed 2010·Granted Aug 12, 2014·5 cites·5 claims
- 0777US8962638B2Piperidine inhibitors of janus kinase 3AUSPEX PHARMACEUTICALS INC·Filed 2012·Granted Feb 24, 2015·2 cites·2 claims
- 0877US8637524B2Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2RAO TADIMETI·Filed 2010·Granted Jan 28, 2014·3 cites·16 claims
- 0977US8586760B2Aminothiazole modulators of beta-3-adrenoreceptorRAO TADIMETI·Filed 2010·Granted Nov 19, 2013·3 cites·16 claims
- 1071US9029407B2Aminothiazole modulators of beta-3-adrenoreceptorAUSPEX PHARMACEUTICALS INC·Filed 2013·Granted May 12, 2015·1 cites·30 claims
- 1169US9260424B24,6-diaminopyrimidine stimulators of soluble guanylate cyclaseRAO TADIMETI·Filed 2010·Granted Feb 16, 2016·1 cites·12 claims
- 1265US9512104B2Quinolone inhibitors of lipoprotein-associated phospholipase A2AUSPEX PHARMACEUTICALS INC·Filed 2013·Granted Dec 6, 2016·0 cites·16 claims
- 1361US9856261B2Piperidine inhibitors of Janus kinase 3AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·0 cites·29 claims
- 1460US2015284327A1Oxindole inhibitors of tyrosine kinaseAUSPEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1557US2008004281A1Methods for the modulation of crp by the selective modulation of ppar deltaKALYPSYS INC·Filed 2007·Application pending·0 cites
- 1656US9493469B2Piperidine inhibitors of Janus kinase 3AUSPEX PHARMACEUTICALS INC·Filed 2015·Granted Nov 15, 2016·0 cites·28 claims
- 1755US2017002015A1Cyclopropyl modulators of p2y12 receptorAUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1854US2016376255A1Quinolone inhibitors of lipoprotein-associated phospholipase a2AUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1947US2016257648A1Oxindole inhibitors of tyrosine kinaseAUSPEX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2044US2016122347A14,6-diaminopyrimidine stimulators of soluble guanylate cyclaseAUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2141US2010317655A1Sulfonamide inhibitors of carbonic anhydraseAUSPEX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2237US2011257260A13,4-methylenedioxyphenyl inhibitors of gaba aminotransferase and/or gaba reuptake transporter inhibitorAUSPEX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2336US2011086847A1Thiadiazole modulators of beta adrenergic receptorAUSPEX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2436US2010291025A1Indazole inhibitors of tyrosine kinaseAUSPEX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2536US2010284970A1Benzimidazole modulators of h1 receptor and/or ns4b proteinAUSPEX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2636US2011054020A1Napthylene inhibitors of cyclooxygenaseAUSPEX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2736US2011306596A1Benzazepine inhibitors of gamma-secretaseRAO TADIMETI·Filed 2010·Application pending·0 cites
- 2836US2011082151A1Sulfonylurea modulators of endothelin receptorAUSPEX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →